Abeona Therapeutics (ABEO) Preferred Dividend Payments (2011 - 2022)
Abeona Therapeutics (ABEO) posted quarterly Preferred Dividend Payments of $3.8 million for Q2 2022, up 452.92% quarter-over-quarter from $684000.0 in Q4 2014.
Powered by 
Analysis
Abeona Therapeutics (ABEO) Preferred Dividend Payments (2011 - 2022) Analysis & Trends
Abeona Therapeutics' Preferred Dividend Payments history runs 5 years deep, the most recent figure standing at $3.8 million for Q2 2022.
- In Q2 2022, Preferred Dividend Payments changed N/A year-over-year to $3.8 million; the TTM figure through Dec 2022 stood at $3.8 million (changed N/A YoY), while the FY2025 annual figure was -$20.3 million, changed N/A from the prior year.
- Preferred Dividend Payments for Q2 2022 stood at $3.8 million, up from $684000.0 in the prior quarter.
- The five-year high for Preferred Dividend Payments was $3.8 million in Q2 2022, with the low at $3.8 million in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 10 | Abeona Therapeutics | 340.29 Mn | 193.47 Mn | 7.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 3.78 Mn |
| Dec 31, 2014 | 684,000.00 |
| Sep 30, 2014 | 740,000.00 |
| Jun 30, 2014 | 726,000.00 |
| Mar 31, 2014 | 725,000.00 |
| Dec 31, 2013 | 696,000.00 |
| Sep 30, 2013 | 742,000.00 |
| Jun 30, 2013 | 733,000.00 |
| Mar 31, 2013 | 727,000.00 |
| Dec 31, 2012 | 676,000.00 |
| Sep 30, 2012 | 444,000.00 |
| Jun 30, 2012 | 439,000.00 |
| Mar 31, 2012 | 440,000.00 |
| Dec 31, 2011 | 447,000.00 |
| Sep 30, 2011 | 447,000.00 |
| Jun 30, 2011 | 442,000.00 |
| Mar 31, 2011 | 438,000.00 |